BioCentury
ARTICLE | Financial News

Decibel raises $55M in series C, names Scangos chairman

June 22, 2018 6:36 PM UTC

Decibel Therapeutics Inc. (Boston, Mass.) raised $55 million on June 19 in a series C round from existing investors Third Rock Venture, GV, SR One and Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) and new investors Foresite Capital, Bessemer Venture Partners, Schroder Adveq, S-Cubed and Longevity. Other new undisclosed institutional investors participated.

Decibel also named George Scangos, a director, as chairman. Scangos, now CEO at Vir Biotechnology Inc. (San Francisco, Calif.), was CEO of Biogen Inc. (NASDAQ:BIIB) from 2010 to 2016 and overlapped at the bellwether with Decibel President and CEO Steven Holtzman. Holtzman was EVP of corporate development at Biogen...